Professor Kazuo Komamura received his medical degree from Osaka University School of Medicine, Japan in 1983. He was trained in Coronary Care Unit, Osaka Police Hospital, Japan. Then, he went abroad to study cellular and molecular mechanisms of heart failure at Prof. Stephen Vatner\'s Laboratory in Cardiovascular Medicine, Harvard Medical School, U.S.A. Coming back to Japan, he was promoted to the Head, Laboratory of Cardiac Dynamics, National Cerebral and Cardiovascular Centre. In 2008, he became a Professor of Pharmaceutical Sciences, Hyogo University of Health Sciences. Currently, he is working as the Director of Osaka Infirmary, Takeda Pharmaceutical, Company Limited as well as an Adjunct Assistant Professor, Cardiovascular Division, Hyogo College of Medicine, Japan. His research focus is on the development of novel therapies for refractory heart failure. He is now a Fellow of American College of Cardiology, American Heart Association, European Society of Cardiology and American College of Physicians.